Carcinoma, Hepatocellular  >>  oxaliplatin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00471965: Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients

Completed
3
371
RoW
Oxaliplatin + 5-Fluorouracil/Leucovorin, Doxorubicin
Sanofi
Carcinoma, Hepatocellular
03/10
03/10
SECOX, NCT01245582: Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients

Withdrawn
3
0
RoW
oxaliplatin (SR96669), capecitabine, sorafenib
Sanofi
Hepatic Neoplasm Malignant
02/14
08/15

Download Options